Fycompa

Nchi: Umoja wa Ulaya

Lugha: Kiingereza

Chanzo: EMA (European Medicines Agency)

Nunua Sasa

Taarifa za kipeperushi Taarifa za kipeperushi (PIL)
10-05-2023
Tabia za bidhaa Tabia za bidhaa (SPC)
10-05-2023

Viambatanisho vya kazi:

perampanel

Inapatikana kutoka:

Eisai GmbH

ATC kanuni:

N03AX22

INN (Jina la Kimataifa):

perampanel

Kundi la matibabu:

Antiepileptics, , Other antiepileptics

Eneo la matibabu:

Epilepsies, Partial

Matibabu dalili:

Fycompa is indicated for the adjunctive treatment of partial-onset seizures with or without secondarily generalised seizures in adult and adolescent patients from 12 years of age with epilepsy.Fycompa is indicated for the adjunctive treatment of primary generalised tonic-clonic seizures in adult and adolescent patients from 12 years of age with idiopathic generalised epilepsy.

Bidhaa muhtasari:

Revision: 32

Idhini hali ya:

Authorised

Idhini ya tarehe:

2012-07-23

Taarifa za kipeperushi

                                69
B. PACKAGE LEAFLET
70
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT
FYCOMPA 2 MG, 4 MG, 6 MG, 8 MG, 10 MG, AND 12 MG FILM-COATED TABLETS
Perampanel
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.
-
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET:
1.
What Fycompa is and what it is used for
2.
What you need to know before you take Fycompa
3.
How to take Fycompa
4.
Possible side effects
5.
How to store Fycompa
6.
Contents of the pack and other information
1.
WHAT FYCOMPA IS AND WHAT IT IS USED FOR
Fycompa contains a medicine called perampanel. It belongs to a group
of medicines called
anti epileptics. These medicines are used to treat epilepsy - where
someone has repeated fits (seizures).
It has been given to you by your doctor to reduce the number of fits
that you have.
Fycompa is used in association with other antiepileptic drugs to treat
certain forms of epilepsy:
In adults, adolescents (aged 12 years and older), and children (from 4
to 11 years)
-
It is used to treat fits that affect one part of your brain (called a
“partial seizure”).
-
These partial seizures may or may not then be followed by a fit
affecting all of your brain
(called a “secondary generalisation”).
In adults and adolescents (aged 12 years and older), and children
(from 7 to 11 years)
-
It is also used to treat certain fits that affect all of your brain
from the start (called “generalised
seizures”) and cause convulsions or staring spells.
2.
WHAT YOU NEED TO KNOW BEFORE YOU TAKE FYCOMPA
DO NOT TAKE FYCOMPA:
-
If you have ever developed a severe skin rash or skin peeling
                                
                                Soma hati kamili
                                
                            

Tabia za bidhaa

                                1
ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
2
1.
NAME OF THE MEDICINAL PRODUCT
Fycompa 2 mg film-coated tablets
Fycompa 4 mg film-coated tablets
Fycompa 6 mg film-coated tablets
Fycompa 8 mg film-coated tablets
Fycompa 10 mg film-coated tablets
Fycompa 12 mg film-coated tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Fycompa 2 mg film-coated tablets
Each film-coated tablet contains 2 mg perampanel.
Excipient with known effect: Each 2 mg tablet contains 78.5 mg of
lactose (as monohydrate).
For the full list of excipients, see section 6.1.
Fycompa 4 mg film-coated tablets
Each film-coated tablet contains 4 mg perampanel.
Excipient with known effect: Each 4 mg tablet contains 157.0 mg of
lactose (as monohydrate).
For the full list of excipients, see section 6.1.
Fycompa 6 mg film-coated tablets
Each film-coated tablet contains 6 mg perampanel.
Excipient with known effect: Each 6 mg tablet contains 151.0 mg of
lactose (as monohydrate).
For the full list of excipients, see section 6.1.
Fycompa 8 mg film-coated tablets
Each film-coated tablet contains 8 mg perampanel.
Excipient with known effect: Each 8 mg tablet contains 149.0 mg of
lactose (as monohydrate).
For the full list of excipients, see section 6.1.
Fycompa 10 mg film-coated tablets
Each film-coated tablet contains 10 mg perampanel.
Excipient with known effect: Each 10 mg tablet contains 147.0 mg of
lactose (as monohydrate).
For the full list of excipients, see section 6.1.
Fycompa 12 mg film-coated tablets
Each film-coated tablet contains 12 mg perampanel.
Excipient with known effect: Each 12 mg tablet contains 145.0 mg of
lactose (as monohydrate).
For the full list of excipients, see section 6.1.
3
3.
PHARMACEUTICAL FORM
Film-coated tablet (tablet)
Fycompa 2 mg film-coated tablets
Orange, round, biconvex tablet, engraved with E275 on one side and
‘2’ on other side
Fycompa 4 mg film-coated tablets
Red, round, biconvex tablet, engraved with E277 on one side and
‘4’ on other side
Fycompa 6 mg film-coated tablets
Pink, round, biconvex tablet, engrav
                                
                                Soma hati kamili
                                
                            

Nyaraka katika lugha zingine

Taarifa za kipeperushi Taarifa za kipeperushi Kibulgaria 10-05-2023
Tabia za bidhaa Tabia za bidhaa Kibulgaria 10-05-2023
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kibulgaria 13-01-2021
Taarifa za kipeperushi Taarifa za kipeperushi Kihispania 10-05-2023
Tabia za bidhaa Tabia za bidhaa Kihispania 10-05-2023
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kihispania 13-01-2021
Taarifa za kipeperushi Taarifa za kipeperushi Kicheki 10-05-2023
Tabia za bidhaa Tabia za bidhaa Kicheki 10-05-2023
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kicheki 13-01-2021
Taarifa za kipeperushi Taarifa za kipeperushi Kidenmaki 10-05-2023
Tabia za bidhaa Tabia za bidhaa Kidenmaki 10-05-2023
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kidenmaki 13-01-2021
Taarifa za kipeperushi Taarifa za kipeperushi Kijerumani 10-05-2023
Tabia za bidhaa Tabia za bidhaa Kijerumani 10-05-2023
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kijerumani 13-01-2021
Taarifa za kipeperushi Taarifa za kipeperushi Kiestonia 10-05-2023
Tabia za bidhaa Tabia za bidhaa Kiestonia 10-05-2023
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kiestonia 13-01-2021
Taarifa za kipeperushi Taarifa za kipeperushi Kigiriki 10-05-2023
Tabia za bidhaa Tabia za bidhaa Kigiriki 10-05-2023
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kigiriki 13-01-2021
Taarifa za kipeperushi Taarifa za kipeperushi Kifaransa 10-05-2023
Tabia za bidhaa Tabia za bidhaa Kifaransa 10-05-2023
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kifaransa 13-01-2021
Taarifa za kipeperushi Taarifa za kipeperushi Kiitaliano 10-05-2023
Tabia za bidhaa Tabia za bidhaa Kiitaliano 10-05-2023
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kiitaliano 13-01-2021
Taarifa za kipeperushi Taarifa za kipeperushi Kilatvia 10-05-2023
Tabia za bidhaa Tabia za bidhaa Kilatvia 10-05-2023
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kilatvia 13-01-2021
Taarifa za kipeperushi Taarifa za kipeperushi Kilithuania 10-05-2023
Tabia za bidhaa Tabia za bidhaa Kilithuania 10-05-2023
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kilithuania 13-01-2021
Taarifa za kipeperushi Taarifa za kipeperushi Kihungari 10-05-2023
Tabia za bidhaa Tabia za bidhaa Kihungari 10-05-2023
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kihungari 13-01-2021
Taarifa za kipeperushi Taarifa za kipeperushi Kimalta 10-05-2023
Tabia za bidhaa Tabia za bidhaa Kimalta 10-05-2023
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kimalta 13-01-2021
Taarifa za kipeperushi Taarifa za kipeperushi Kiholanzi 10-05-2023
Tabia za bidhaa Tabia za bidhaa Kiholanzi 10-05-2023
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kiholanzi 13-01-2021
Taarifa za kipeperushi Taarifa za kipeperushi Kipolandi 10-05-2023
Tabia za bidhaa Tabia za bidhaa Kipolandi 10-05-2023
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kipolandi 13-01-2021
Taarifa za kipeperushi Taarifa za kipeperushi Kireno 10-05-2023
Tabia za bidhaa Tabia za bidhaa Kireno 10-05-2023
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kireno 13-01-2021
Taarifa za kipeperushi Taarifa za kipeperushi Kiromania 10-05-2023
Tabia za bidhaa Tabia za bidhaa Kiromania 10-05-2023
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kiromania 13-01-2021
Taarifa za kipeperushi Taarifa za kipeperushi Kislovakia 10-05-2023
Tabia za bidhaa Tabia za bidhaa Kislovakia 10-05-2023
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kislovakia 13-01-2021
Taarifa za kipeperushi Taarifa za kipeperushi Kislovenia 10-05-2023
Tabia za bidhaa Tabia za bidhaa Kislovenia 10-05-2023
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kislovenia 13-01-2021
Taarifa za kipeperushi Taarifa za kipeperushi Kifinlandi 10-05-2023
Tabia za bidhaa Tabia za bidhaa Kifinlandi 10-05-2023
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kifinlandi 13-01-2021
Taarifa za kipeperushi Taarifa za kipeperushi Kiswidi 10-05-2023
Tabia za bidhaa Tabia za bidhaa Kiswidi 10-05-2023
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kiswidi 13-01-2021
Taarifa za kipeperushi Taarifa za kipeperushi Kinorwe 10-05-2023
Tabia za bidhaa Tabia za bidhaa Kinorwe 10-05-2023
Taarifa za kipeperushi Taarifa za kipeperushi Kiaisilandi 10-05-2023
Tabia za bidhaa Tabia za bidhaa Kiaisilandi 10-05-2023
Taarifa za kipeperushi Taarifa za kipeperushi Kroeshia 10-05-2023
Tabia za bidhaa Tabia za bidhaa Kroeshia 10-05-2023
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kroeshia 13-01-2021

Tafuta arifu zinazohusiana na bidhaa hii

Tazama historia ya hati